Oxymatrine inhibits non-small cell lung cancer via suppression of EGFR signaling pathway

Driven by Mutations: The Predictive Value of Mutation Subtype in EGFR -Mutated Non–Small Cell Lung Cancer

(2017) Emily Castellanos et al.   Journal of Thoracic Oncology

Optimal management of EGFR -mutant non-small cell lung cancer with disease progression on first-line tyrosine kinase inhibitor therapy

(2017) Bin-Chi Liao et al.   LUNG CANCER

Neoalbaconol inhibits angiogenesis and tumor growth by suppressing EGFR-mediated VEGF production

(2017) Xinfang Yu et al.   MOLECULAR CARCINOGENESIS

Osimertinib: A Review in T790M-Positive Advanced Non-Small Cell Lung Cancer

(2017) Yvette N. Lamb et al.   Targeted Oncology

Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms

(2017) Claudia Proto et al.   TUMORI

Oxymatrine inhibits proliferation of human bladder cancer T24 cells by inducing apoptosis and cell cycle arrest

(2017) Shun Li et al.   Oncology Letters

PGE2/EP3/SRC signaling induces EGFR nuclear translocation and growth through EGFR ligands release in lung adenocarcinoma cells

(2017) Lorenzo Bazzani et al.   Oncotarget

Treatment in EGFR-mutated Non-small Cell Lung Cancer: How to Block the Receptor and overcome Resistance Mechanisms

(2017) Claudia Proto et al.   TUMORI JOURNAL

Oxymatrine synergistically enhances antitumor activity of oxaliplatin in colon carcinoma through PI3K/AKT/mTOR pathway

(2016) Yan Liu et al.   APOPTOSIS

Targeting the EGFR T790M mutation in non-small-cell lung cancer

(2016) Nicola Normanno et al.   EXPERT OPINION ON THERAPEUTIC TARGETS

Oxymatrine inhibits the migration of human colorectal carcinoma RKO cells via inhibition of PAI-1 and the TGF-β1/Smad signaling pathway

(2016) Xiaoyu Wang et al.   ONCOLOGY REPORTS

Oxymatrine suppresses proliferation and facilitates apoptosis of human ovarian cancer cells through upregulating microRNA-29b and downregulating matrix metalloproteinase-2 expression

(2015) JINGWEI LI et al.   Molecular Medicine Reports

Oxymatrine inhibits the proliferation of prostate cancer cells in vitro and in vivo

(2015) CUNZAO WU et al.   Molecular Medicine Reports

Refining the treatment of NSCLC according to histological and molecular subtypes

(2015) Anish Thomas et al.   Nature Reviews Clinical Oncology

Oxymatrine synergistically enhances the inhibitory effect of 5-fluorouracil on hepatocellular carcinoma in vitro and in vivo

(2015) Yan Liu et al.   TUMOR BIOLOGY

Cancer treatment and survivorship statistics, 2014

(2014) Carol E. DeSantis et al.   CA-A CANCER JOURNAL FOR CLINICIANS

Oxymatrine targets EGFRp-Tyr845 and inhibits EGFR-related signaling pathways to suppress the proliferation and invasion of gastric cancer cells

(2014) Bingyu Guo et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

Comprehensive molecular profiling of lung adenocarcinoma

(2014) Eric A. Collisson et al.   NATURE

Optimizing lung cancer treatment approaches

(2014) Rafael Rosell et al.   Nature Reviews Clinical Oncology

Anti-tumor activities of matrine and oxymatrine: literature review

(2014) Yan Liu et al.   TUMOR BIOLOGY

Cancer statistics, 2013

(2013) Rebecca Siegel et al.   CA-A CANCER JOURNAL FOR CLINICIANS

TRAF4 Is a Critical Molecule for Akt Activation in Lung Cancer

(2013) W. Li et al.   CANCER RESEARCH

Antiangiogenic effects of oxymatrine on pancreatic cancer by inhibition of the NF-κB-mediated VEGF signaling pathway

(2013) HUI CHEN et al.   ONCOLOGY REPORTS

Nuclear EGFR as a molecular target in cancer

(2013) Toni M. Brand et al.   RADIOTHERAPY AND ONCOLOGY

Landscape of EGFR signaling network in human cancers: Biology and therapeutic response in relation to receptor subcellular locations

(2012) Woody Han et al.   CANCER LETTERS

Hallmarks of Cancer: The Next Generation

(2011) Douglas Hanahan et al.   CELL

Nuclear EGFR as Novel Therapeutic Target

(2010) Klaus Dittmann et al.   STRAHLENTHERAPIE UND ONKOLOGIE

Clinical Definition of Acquired Resistance to Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors in Non–Small-Cell Lung Cancer

(2009) David Jackman et al.   JOURNAL OF CLINICAL ONCOLOGY

Lung Cancer

(2008) Roy S. Herbst et al.   NEW ENGLAND JOURNAL OF MEDICINE